TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36494716

Group type: EXPERIMENTAL
Intervention: Intervention group GPs trained in the use of a patient education booklet during low back pain patient visits.
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group GPs providing usual care.
Number of subjects: 19
Study: 32241373

Group type: EXPERIMENTAL
Intervention: 4-month educational intervention (the SI! Program)
Number of subjects: 1216

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1216
Study: 35854391

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula oxygen therapy (HFNC)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 562
Study: 33682773

Group type: EXPERIMENTAL
Intervention: Respiratory and core-postural stabilisation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Abdominal breathing
Number of subjects: 14
Study: 34483640

Group type: EXPERIMENTAL
Intervention: Lowest postoperative pre-albumin < 15 mg/dL
Number of subjects: 436
Study: 33050362

Group type: EXPERIMENTAL
Intervention: HBOT treatment after exercise in NN conditions (HNN group)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: HBOT treatment after exercise in HH conditions (HHH group)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Exercise in NN conditions (NN group)
Number of subjects: 18
Study: 616871163

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise (at least 30 min per day, 5 times weekly)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (recommended exercise of the same intensity but not mandatory)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 35818787

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy (MBCT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 20
Study: 34625284

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg/day
Number of subjects: 39
Study: 36322059

Group type: EXPERIMENTAL
Intervention: Patient-reported data
Number of subjects: 15076

Group type: COMPARATOR
Intervention: Electronic health record data
Number of subjects: 15076

Group type: EXPERIMENTAL
Intervention: Patient report of clinical endpoints
Number of subjects: 15076

Group type: EXPERIMENTAL
Intervention: Coronary revascularization
Number of subjects: 15076
Study: 34340880

Group type: EXPERIMENTAL
Intervention: 0.75% citric acid spray
Number of subjects: 112

Group type: COMPARATOR
Intervention: Cool water spray
Number of subjects: 112
Study: 35220330

Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) pregabalin (150 to 600 mg/d) once daily for 12 weeks
Number of subjects: 371

Group type: COMPARATOR
Intervention: Immediate-release (IR) pregabalin (150 to 600 mg/d) twice daily for 12 weeks
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) pregabalin
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Both SR and IR pregabalin
Number of subjects: 371
Study: 32059724

Group type: EXPERIMENTAL
Intervention: Tailored support recommendations (n=171 caregivers)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Recommendations concerning mental health
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Recommendations concerning physical health
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Recommendations concerning social, legal, and financial affairs
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Recommendations concerning social integration (especially caregiver supporting groups)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Caregiver supporting groups
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Functional status of the PwD
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Activities of daily living abilities of the PwD
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Cognition and depression status of the PwD
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Physical and mental health of family dementia caregivers
Number of subjects: 226
Study: 34226214

Group type: EXPERIMENTAL
Intervention: Enhanced occupational therapy discharge planning intervention (the HOME programme) including pre and postdischarge home visits, goal setting, and occupational therapy in the home.
Number of subjects: 360

Group type: COMPARATOR
Intervention: Standardised discharge planning intervention (control group).
Number of subjects: 360
Study: 32325078

Group type: EXPERIMENTAL
Intervention: Regular repetition schedule of musical patterns
Number of subjects: 0

Group type: COMPARATOR
Intervention: Irregular repetition schedule of musical patterns
Number of subjects: 0
Study: 35370039

Group type: EXPERIMENTAL
Intervention: 3 months of adjuvant doublet chemotherapy (CAPOX)
Number of subjects: 2310

Group type: EXPERIMENTAL
Intervention: 3 months of adjuvant doublet chemotherapy
Number of subjects: 2310
Study: 33831698

Group type: EXPERIMENTAL
Intervention: Dry needling (DN) to the thoracolumbar junction multifidi
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham dry needling (sham DN) to the thoracolumbar junction multifidi
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham dry needling (sham DN)
Number of subjects: 54
Study: 32711551

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 8107

Group type: COMPARATOR
Intervention: Clinician-recorded times
Number of subjects: 8107

Group type: EXPERIMENTAL
Intervention: Monitored times
Number of subjects: 8107
Study: 32058362

Group type: EXPERIMENTAL
Intervention: 12-SET
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 18-SET
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 24-SET
Number of subjects: 35
Study: 33336381

Group type: EXPERIMENTAL
Intervention: Bumetanide (diuretic agent)
Number of subjects: 6
Study: 34051017

Group type: EXPERIMENTAL
Intervention: Emergency Department (ED) attendance with lower urgency problems
Number of subjects: 400
Study: 32278674

Group type: EXPERIMENTAL
Intervention: Daratumumab plus VMP (D-VMP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: VMP
Number of subjects: 0

Group type: COMPARATOR
Intervention: ALCYONE VMP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ALCYONE D-VMP
Number of subjects: 0
Study: 35777873

Group type: EXPERIMENTAL
Intervention: Med Safety mobile application training for healthcare professionals
Number of subjects: 382

Group type: COMPARATOR
Intervention: Paper-based and web-based reporting training
Number of subjects: 382
Study: 33756023

Group type: EXPERIMENTAL
Intervention: High-demand 'working memory' task
Number of subjects: 57

Group type: COMPARATOR
Intervention: Low-demand 'motor control' task
Number of subjects: 57
Study: 35609163

Group type: EXPERIMENTAL
Intervention: 1 text message reminder (sent 2 business days prior to the appointment)
Number of subjects: 158669

Group type: COMPARATOR
Intervention: 2 text message reminders (sent 2 and 3 days prior)
Number of subjects: 158669
Study: 34037753

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 34133004

Group type: EXPERIMENTAL
Intervention: Truthful responding condition
Number of subjects: 1502

Group type: COMPARATOR
Intervention: Binge Eating Disorder (BED) condition
Number of subjects: 1502

Group type: COMPARATOR
Intervention: Anorexia Nervosa (AN) condition
Number of subjects: 1502

Group type: COMPARATOR
Intervention: Bulimia Nervosa (BN) condition
Number of subjects: 1502

Group type: EXPERIMENTAL
Intervention: General UDEBS scores
Number of subjects: 1502

Group type: EXPERIMENTAL
Intervention: Gender analysis
Number of subjects: 1502
Study: 34623899

Group type: EXPERIMENTAL
Intervention: Surgery only (Arm A)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: 55.8 Gy radiotherapy (Arm B)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Ifosfamide and doxorubicin chemotherapy plus 55.8 Gy RT (Arm C)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Neoadjuvant ifosfamide and 45 Gy RT, then surgery and RT boost (Arm D)
Number of subjects: 138
Study: 35510727

Group type: EXPERIMENTAL
Intervention: Epilepsy group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Epilepsy group with comorbid psychiatric diseases
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Epilepsy group using psychiatric drugs
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Epilepsy group (girls)
Number of subjects: 56
Study: 32804843

Group type: EXPERIMENTAL
Intervention: Investigational product (liquid sachets containing hyaluronic acid, amino acids, and rice extract)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 35752301

Group type: EXPERIMENTAL
Intervention: Medical management with misoprostol (800 μg sublingually)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 131
Study: 33059765

Group type: EXPERIMENTAL
Intervention: Repeated short‐term fasting with a maximum energy supply of 350–400 kcal on fasting days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Repeated short‐term normocaloric plant‐based diet with restriction of refined carbohydrates
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Repeated short‐term fasting
Number of subjects: 150
Study: 33720329

Group type: EXPERIMENTAL
Intervention: VIPP-SD (Video‐feedback Intervention to promote Positive Parenting and Sensitive Discipline)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: VIPP-SD
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study: 36414990

Group type: EXPERIMENTAL
Intervention: Mandibular overdentures retained by 4 interforaminal implants (Test)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mandibular overdentures retained by 2 interforaminal implants (Control)
Number of subjects: 20
Study: 32389326

Group type: EXPERIMENTAL
Intervention: Contezolid (MRX-I) 600 mg BID for 14 days under fed conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contezolid (MRX-I) 800 mg BID for 14 days under fed conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contezolid (MRX-I) 800 mg BID for 7-14 days under fed conditions
Number of subjects: 0
Study: 34922353

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18109
Study: 33606713

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (20,000 IU for <6 months, 50,000 IU for 6-12 months, 100,000 IU for 13-59 months on the first day, followed by 10,000 IU maintenance for next 4 days)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 36073727

Group type: EXPERIMENTAL
Intervention: HoloLens2™ enhanced remote case-based teaching
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional remote case-based teaching
Number of subjects: 56
Study: 33615976

Group type: EXPERIMENTAL
Intervention: Below-elbow cast (BEC)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Above-elbow cast (AEC)
Number of subjects: 51
Study: 35867073

Group type: EXPERIMENTAL
Intervention: Normoxia moderate (NM)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hypoxia moderate (HM)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Normoxia intensive (NI)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hypoxia intensive (HI)
Number of subjects: 28
Study: 33905606

Group type: EXPERIMENTAL
Intervention: IVC clamping
Number of subjects: 120

Group type: COMPARATOR
Intervention: Non-IVC clamping
Number of subjects: 120
Study: 34974527

Group type: EXPERIMENTAL
Intervention: Daratumumab plus lenalidomide/dexamethasone (D‐Rd)
Number of subjects: 737
Study: 33298040

Group type: EXPERIMENTAL
Intervention: MF + CBL model
Number of subjects: 104

Group type: COMPARATOR
Intervention: LBL model
Number of subjects: 104
Study: 35191384

Group type: EXPERIMENTAL
Intervention: Proximal ulnar nerve anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distal ulnar nerve anesthesia
Number of subjects: 60
Study: 33231317

Group type: EXPERIMENTAL
Intervention: Manipulated social status using a false feedback paradigm in Study 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulated meritocracy using a scrambled sentence task in Study 3
Number of subjects: 0
Study: 32234041

Group type: EXPERIMENTAL
Intervention: SAFMEDS intervention group (n=13)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Usual teaching control group (n=14)
Number of subjects: 27
Study: 33896930

Group type: EXPERIMENTAL
Intervention: Paclitaxel drug-coated balloons (Pantera Lux)
Number of subjects: 199
Study: 35660972

Group type: EXPERIMENTAL
Intervention: Pembrolizumab and chemotherapy
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Mesothelioma risk score (MRS) based on SII and haemoglobin levels
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Mesothelioma risk score (MRS)
Number of subjects: 144
Study: 34175866

Group type: EXPERIMENTAL
Intervention: Closed‐incision negative‐pressure therapy (ciNPT)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Conventional surgical dressing (control)
Number of subjects: 148
Study: 35858590

Group type: EXPERIMENTAL
Intervention: Nivolumab plus chemotherapy
Number of subjects: 0
Study: 34146251

Group type: EXPERIMENTAL
Intervention: NiTi systems (Reciproc® Blue)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: NiTi systems (MTwo®)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Manual stainless-steel instrumentation
Number of subjects: 57

Group type: COMPARATOR
Intervention: Manual instrumentation
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: All systems
Number of subjects: 57
Study: 32207137

Group type: EXPERIMENTAL
Intervention: Caudal Regional Anesthesia (CRA)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Intrarectal Local Anesthesia (IRLA)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Periprostatic Local Anesthesia (PPLA)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Combined Local Anesthesia (IRLA+PPLA)
Number of subjects: 160
Study: 34355753

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6614

Group type: EXPERIMENTAL
Intervention: Meta-regression
Number of subjects: 6614

Group type: EXPERIMENTAL
Intervention: MetaForest
Number of subjects: 6614
Study: 33792788

Group type: EXPERIMENTAL
Intervention: Ranibizumab (RBZ) therapy, 0.5 or 2.0 mg, monthly intravitreal injections for 6 consecutive injections followed by as-needed treatments.
Number of subjects: 123
Study: 32303377

Group type: EXPERIMENTAL
Intervention: Sphenopalatine ganglion block with local anaesthetic (lidocaine 4% and ropivacaine 0.5%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sphenopalatine ganglion block with local anaesthetic
Number of subjects: 40
Study: 35065922

Group type: EXPERIMENTAL
Intervention: FAITH! App (immediate intervention)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Delayed intervention comparator group
Number of subjects: 85
Study: 33709192

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-soaked nasal packing (1 μg kg−1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-soaked nasal packing (2 μg kg−1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-soaked nasal packing (4 μg kg−1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline-soaked nasal packing (Control)
Number of subjects: 80
Study: 32346979

Group type: EXPERIMENTAL
Intervention: Citing predatory journal articles
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Four predatory journal articles
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Quality evaluation of cited predatory articles
Number of subjects: 204
Study: 35219923

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (active group, n = 18)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham tDCS (sham group, n = 18)
Number of subjects: 36
Study: 33401694

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise
Number of subjects: 16

Group type: COMPARATOR
Intervention: Resistance Exercise
Number of subjects: 16
Study: 35026851

Group type: EXPERIMENTAL
Intervention: Early cord clamping (ECC)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Cut-umbilical cord milking (C-UCM)
Number of subjects: 69
Study: 34941937

Group type: EXPERIMENTAL
Intervention: Vonoprazan
Number of subjects: 408

Group type: COMPARATOR
Intervention: PPI
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Combined data from RCT and observational study
Number of subjects: 408
Study: 36327043

Group type: EXPERIMENTAL
Intervention: SC‐R group (n=29) - 24 weeks of no cost Nicotine Replacement Treatment (NRT)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: SC + group (n=32) - 24 weeks of no cost NRT plus two initial individual counselling sessions of motivational interviewing and weekly psychosocial group support for 24 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 61
Study: 33855868

Group type: EXPERIMENTAL
Intervention: Selinexor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32109729

Group type: EXPERIMENTAL
Intervention: Skills preparation group
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Birth stories group
Number of subjects: 174

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) group
Number of subjects: 174
Study: 35238013

Group type: EXPERIMENTAL
Intervention: Opioid-free anesthesia (OFA) technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 80
Study: 32847754

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIP)
Number of subjects: 588

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 588
Study: 33827012

Group type: EXPERIMENTAL
Intervention: CCT‐C‐PM intervention (Cognitive Compensatory Training)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Occupational therapy only
Number of subjects: 72
Study: 35222879

Group type: EXPERIMENTAL
Intervention: Psychological intervention combined with health education
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine nursing intervention
Number of subjects: 70
Study: 33831949

Group type: EXPERIMENTAL
Intervention: Antioxidant cocktail (741 mg/d polyphenols, 2.1 g/d omega-3 fatty acids, 168 mg/d vitamin E, and 80 μg/d selenium)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No supplement (Control)
Number of subjects: 20
Study: 34196905

Group type: EXPERIMENTAL
Intervention: Building Bridges to Fatherhood (BBTF) program
Number of subjects: 178

Group type: COMPARATOR
Intervention: Money Smart Financial Literacy Program (MSFLP)
Number of subjects: 178
Study: 35193619

Group type: EXPERIMENTAL
Intervention: TEAM
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LEAD
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: TEAM + LEAD
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard REP only
Number of subjects: 24
Study: 33736821

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3730

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3730
Study: 32703257

Group type: EXPERIMENTAL
Intervention: Knowledge brokering intervention performed in 7 stages based on Dobbins' knowledge translation framework 2009.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison group (control) without knowledge brokering intervention.
Number of subjects: 100
Study: 36380749

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting lung metastasis
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival rates
Number of subjects: 618
Study: 34791283

Group type: EXPERIMENTAL
Intervention: PP6M (700 or 1000 mg eq.)
Number of subjects: 702

Group type: COMPARATOR
Intervention: PP3M (350 or 525 mg eq.)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: PP6M
Number of subjects: 702

Group type: COMPARATOR
Intervention: PP3M
Number of subjects: 702

Group type: COMPARATOR
Intervention: PP6M vs PP3M
Number of subjects: 702
Study: 33259257

Group type: EXPERIMENTAL
Intervention: Exercise days (aerobic, high-intensity interval, or resistance-based exercise)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sedentary days
Number of subjects: 0
Study: 32004582

Group type: EXPERIMENTAL
Intervention: Ultrahypofractionated radiation therapy (UHF) - 7 × 6.1 Gy, 2.5 weeks
Number of subjects: 673

Group type: COMPARATOR
Intervention: Conventionally fractionated radiation therapy (CF) - 39 × 2.0 Gy, 8 weeks
Number of subjects: 673
Study: 34431071

Group type: EXPERIMENTAL
Intervention: Vosoritide 15 µg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vosoritide 30 µg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32540887

Group type: EXPERIMENTAL
Intervention: Breathing exercises, foot reflexology and back massage (BRM) with standard labour care
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard labour care
Number of subjects: 154
Study: 34554831

Group type: EXPERIMENTAL
Intervention: Acid-oxidising solution (AOS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 50
Study: 32217557

Group type: EXPERIMENTAL
Intervention: SFX-01 (300 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 34253584

Group type: EXPERIMENTAL
Intervention: Ruxolitinib (20 mg twice daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ruxolitinib
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 50
Study: 34694204

Group type: EXPERIMENTAL
Intervention: Minimally invasive fusion of the sacroiliac joint
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham operation
Number of subjects: 60
Study: 33605509

Group type: COMPARATOR
Intervention: Intermittent theta burst stimulation (iTBS)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High-impulsive individuals
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Low-impulsive individuals
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Single-trial preresponse theta phase clustering
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Performance monitoring
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Current stimulation protocol
Number of subjects: 45
Study: 32154847

Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy
Number of subjects: 148

Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 148